Life Science AllianceGeneticsPeer-reviewed journal article
Loss of SET1/COMPASS methyltransferase activity reduces lifespan and fertility in Caenorhabditis elegans
Matthieu J. CaroniD, Loïc GelyiD, Steve GarvisiD, Annie AdraitiD, Yohann CoutéiD, Francesca PalladinoiD, Paola FabrizioiD
Abstract
Post-translational modification of histones, particularly lysine methylation, are thought to play a crucial role in the aging process. Histone 3 lysine 4 (H3K4) methylation, a modification associated with active chromatin, is mediated by a family of SET1 methyltransferases acting within conserved multiprotein complexes known as COMPASS. Previous work in model organisms with partial or complete deletion of COMPASS subunits has yielded conflicting results about the requirement for H3K4 methylation during aging. Here, we reassessed the role of SET1/COMPASS-dependent H3K4 methylation in Caenorhabditis elegans lifespan regulation and fertility by generating set-2(syb2085) mutant animals that express a catalytically inactive form of SET-2, the C. elegans homolog of SET1. We show that animals bearing catalytically inactive SET-2 retain the ability to form COMPASS complexes but have a marked global loss of H3K4 dimethylation and trimethylation. Consistent with previous work, reduced H3K4 methylation was accompanied by loss of fertility; however, in striking contrast to earlier studies, set-2(syb2085) mutants displayed a significantly shortened, not extended, lifespan and had normal intestinal fat stores. Furthermore, other commonly used set-2 mutants were also short-lived, as was a cfp-1 mutant that lacks a non-catalytic SET1/COMPASS component and displays reduced H3K4 methylation. These results challenge previously held views and establish that wild-type H3K4 methylation levels are necessary to achieve a normal lifespan in C. elegans.
- organism: C. elegans
- assay: ChIP-seq
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 15
- FWCI
- 0.89
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Confirming the Pro-longevity Effects of H3K4me3-deficient set-2 Mutants in Extending Lifespan in C. elegans
Carlos G. Silva-García, William B. Mair·bioRxiv·Aug 2, 2022
- H3K9me2 protects lifespan against the transgenerational burden of germline transcription in C. elegans
Teresa Wei-sy Lee, Heidi Shira David, … David J. Katz·eLifePeer-reviewed·Dec 9, 2019
- H3K9me1/2 methylation limits the lifespan of C. elegans
Meng Huang, Minjie Hong, … Xuezhu Feng·eLifePeer-reviewed·Sep 20, 2022
- CRTC-1 Balances Histone Trimethylation and Acetylation to Promote Longevity
Carlos G. Silva-García, Laura Ivón Láscarez-Lagunas, … William B. Mair·bioRxiv·Aug 31, 2022
- Cooperation between Caenorhabditis elegans COMPASS and condensin in germline chromatin organization
Marion Herbette, Valérie J. P. Robert, … Francesca Palladino·bioRxiv·May 26, 2020
- The C. elegans SET-2 histone methyltransferase maintains germline fate by preventing progressive transcriptomic deregulation across generations
Valérie J. P. Robert, Andrew Kekūpaʻa Knutson, … Francesca Palladino·bioRxiv·Mar 21, 2019